Nombre de publicacions
547
Cercador de publicacions
  • Soria X; Vilardell F; Maiques Ó; Barceló C; Sisó P; de la Rosa I; Velasco A; Cuevas D; Santacana M; Gatius S; Matías-Guiu X; Rodrigo A; Macià A; Martí RM

    BRAF(V600E)

    Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics

    Cancers 13 -. .

    [doi:10.3390/cancers13205073]

  • Eritja N; Navaridas R; Ruiz-Mitjana A; Vidal-Sabanés M; Egea J; Encinas M; Matias-Guiu X; Dolcet X

    Endometrial PTEN Deficiency Leads to SMAD2/3 Nuclear Translocation

    Cancers 13 -. .

    [doi:10.3390/cancers13194990]

  • Manning-Geist BL; Gatius S; Liu Y; Gil M; Da Cruz Paula A; Tuset N; Abu-Rustum NR; Aghajanian C; Weigelt B; Matias-Guiu X

    Diagnosis and management of an endometrial cancer patient with Cowden syndrome.

    GYNECOLOGIC ONCOLOGY 163 14-21. .

    [doi:10.1016/j.ygyno.2021.08.008]

  • CERDAN SANTACRUZ, CARLOS; CODINA CORRONS, LAIA; MERICHAL RESINA, MIREIA; MILLA COLLADO, LUCIA; TRUJILLANO CABELLO, JOSE JAVIER; TARRAGONA FORADADA, JORDI; MESTRES PETIT, NURIA; SIERRA GRAÑON, JOSE E; OLSINA KISSLER, JORGE J.

    Factors associated with higher rate of Complete Pathologic Response after Long-Course Neoadjuvant Treatment for Locally Advanced Rectal Cancer Patients – Results from a retrospective cohort study focused on Inflammatory Indexes

    Iranian Journal of colorectal research 9 90-97. .

    [doi:10.30476/ACRR.2021.47811]

  • López-Fernández, A; Villacampa, G; Grau, E; Salinas, M; Darder, E; Carrasco, E; Torres-Esquius, S; Iglesias, S; Solanes, A; Gadea, N; Velasco, A; Urgell, G; Torres, M; Tuset, N; Brunet, J; Corbella, S; Balmaña, J

    Patients' and professionals' perspective of non-in-person visits in hereditary cancer: predictors and impact of the COVID-19 pandemic

    GENETICS IN MEDICINE 23 1450-1457. .

    [doi:10.1038/s41436-021-01157-2]

  • Barés G; Beà A; Hernández L; Navaridas R; Felip I; Megino C; Blasco N; Nadeu F; Campo E; Llovera M; Dolcet X; Sanchis D

    ENDOG Impacts on Tumor Cell Proliferation and Tumor Prognosis in the Context of PI3K/PTEN Pathway Status.

    Cancers 13 -. .

    [doi:10.3390/cancers13153803]

  • Guerra E; Matias-Guiu X

    Relevance of pathologic features in risk stratification for early-stage endometrial cancer.

    Journal of Gynecologic Oncology 32 -. .

    [doi:10.3802/jgo.2021.32.e67]

  • Munoz, CC; Rodriguez, JG; Rivera, AA; Estaran, E; Carcel, JR; Medrano, AS

    Systemic sclerosis and microscopic polyangiitis after systemic exposure to silicone

    CLINICAL KIDNEY JOURNAL 14 1848-1850. .

    [doi:10.1093/ckj/sfab058]

  • Ojanguren A; Santamaría M; Milla-Collado L; Fraile C; Gatius-Calderó S; Puy S; Boldó A; Gómez-Olles S; Boada-Pérez M; Esquinas C; Sáez-Giménez B; Ojanguren I; Barrecheguren M; Olsina-Kissler JJ

    Pilot Trial of Extended Hypothermic Lung Preservation to Analyze Ischemia-reperfusion Injury in Pigs.

    ARCHIVOS DE BRONCONEUMOLOGIA 57 479-489. .

    [doi:10.1016/j.arbr.2021.03.015]

  • Sanegre S; Eritja N; de Andrea C; Diaz-Martin J; Diaz-Lagares Á; Jácome MA; Salguero-Aranda C; García Ros D; Davidson B; Lopez R; Melero I; Navarro S; Ramon Y Cajal S; de Alava E; Matias-Guiu X; Noguera R

    Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma.

    Frontiers In Cell And Developmental Biology 9 670185-670185. .

    [doi:10.3389/fcell.2021.670185]

  • Buza N; Euscher ED; Matias-Guiu X; McHenry A; Oliva E; Ordulu Z; Parra-Herran C; Rottmann D; Turner BM; Wong S; Hui P

    Reproducibility of scoring criteria for HER2 immunohistochemistry in endometrial serous carcinoma: a multi-institutional interobserver agreement study.

    Modern Pathology 34 1194-1202. .

    [doi:10.1038/s41379-021-00746-5]

  • Concin N; Matias-Guiu X; Creutzberg CL; ESGO-ESTRO-ESP Endometrial Carcinoma Guideline Working Group

    Response to: Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 31 947-947. .

    [doi:10.1136/ijgc-2021-002668]